Cargando…
Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project
ROADMAP is a public-private advisory partnership to evaluate the usability of multiple data sources, including real-world evidence, in the decision-making process for new treatments in Alzheimer’s disease, and to advance key concepts in disease and pharmacoeconomic modeling. ROADMAP identified key d...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398537/ https://www.ncbi.nlm.nih.gov/pubmed/30584137 http://dx.doi.org/10.3233/JAD-180370 |
| _version_ | 1783399597614301184 |
|---|---|
| author | Gallacher, John de Reydet de Vulpillieres, Frederic Amzal, Billy Angehrn, Zuzanna Bexelius, Christin Bintener, Christophe Bouvy, Jacoline C. Campo, Laura Diaz, Carlos Georges, Jean Gray, Alastair Hottgenroth, Antje Jonsson, Pall Mittelstadt, Brent Potashman, Michele H. Reed, Catherine Sudlow, Cathie Thompson, Robin Tockhorn-Heidenreich, Antje Turner, Andrew van der Lei, Johan Visser, Pieter Jelle |
| author_facet | Gallacher, John de Reydet de Vulpillieres, Frederic Amzal, Billy Angehrn, Zuzanna Bexelius, Christin Bintener, Christophe Bouvy, Jacoline C. Campo, Laura Diaz, Carlos Georges, Jean Gray, Alastair Hottgenroth, Antje Jonsson, Pall Mittelstadt, Brent Potashman, Michele H. Reed, Catherine Sudlow, Cathie Thompson, Robin Tockhorn-Heidenreich, Antje Turner, Andrew van der Lei, Johan Visser, Pieter Jelle |
| author_sort | Gallacher, John |
| collection | PubMed |
| description | ROADMAP is a public-private advisory partnership to evaluate the usability of multiple data sources, including real-world evidence, in the decision-making process for new treatments in Alzheimer’s disease, and to advance key concepts in disease and pharmacoeconomic modeling. ROADMAP identified key disease and patient outcomes for stakeholders to make informed funding and treatment decisions, provided advice on data integration methods and standards, and developed conceptual cost-effectiveness and disease models designed in part to assess whether early treatment provides long-term benefit. |
| format | Online Article Text |
| id | pubmed-6398537 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | IOS Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63985372019-03-06 Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project Gallacher, John de Reydet de Vulpillieres, Frederic Amzal, Billy Angehrn, Zuzanna Bexelius, Christin Bintener, Christophe Bouvy, Jacoline C. Campo, Laura Diaz, Carlos Georges, Jean Gray, Alastair Hottgenroth, Antje Jonsson, Pall Mittelstadt, Brent Potashman, Michele H. Reed, Catherine Sudlow, Cathie Thompson, Robin Tockhorn-Heidenreich, Antje Turner, Andrew van der Lei, Johan Visser, Pieter Jelle J Alzheimers Dis Editorial ROADMAP is a public-private advisory partnership to evaluate the usability of multiple data sources, including real-world evidence, in the decision-making process for new treatments in Alzheimer’s disease, and to advance key concepts in disease and pharmacoeconomic modeling. ROADMAP identified key disease and patient outcomes for stakeholders to make informed funding and treatment decisions, provided advice on data integration methods and standards, and developed conceptual cost-effectiveness and disease models designed in part to assess whether early treatment provides long-term benefit. IOS Press 2019-01-22 /pmc/articles/PMC6398537/ /pubmed/30584137 http://dx.doi.org/10.3233/JAD-180370 Text en © 2019 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Gallacher, John de Reydet de Vulpillieres, Frederic Amzal, Billy Angehrn, Zuzanna Bexelius, Christin Bintener, Christophe Bouvy, Jacoline C. Campo, Laura Diaz, Carlos Georges, Jean Gray, Alastair Hottgenroth, Antje Jonsson, Pall Mittelstadt, Brent Potashman, Michele H. Reed, Catherine Sudlow, Cathie Thompson, Robin Tockhorn-Heidenreich, Antje Turner, Andrew van der Lei, Johan Visser, Pieter Jelle Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project |
| title | Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project |
| title_full | Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project |
| title_fullStr | Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project |
| title_full_unstemmed | Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project |
| title_short | Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project |
| title_sort | challenges for optimizing real-world evidence in alzheimer’s disease: the roadmap project |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398537/ https://www.ncbi.nlm.nih.gov/pubmed/30584137 http://dx.doi.org/10.3233/JAD-180370 |
| work_keys_str_mv | AT gallacherjohn challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT dereydetdevulpillieresfrederic challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT amzalbilly challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT angehrnzuzanna challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT bexeliuschristin challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT bintenerchristophe challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT bouvyjacolinec challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT campolaura challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT diazcarlos challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT georgesjean challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT grayalastair challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT hottgenrothantje challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT jonssonpall challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT mittelstadtbrent challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT potashmanmicheleh challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT reedcatherine challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT sudlowcathie challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT thompsonrobin challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT tockhornheidenreichantje challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT turnerandrew challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT vanderleijohan challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT visserpieterjelle challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject AT challengesforoptimizingrealworldevidenceinalzheimersdiseasetheroadmapproject |